Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000416074 | SCV000493540 | pathogenic | not provided | 2022-11-01 | criteria provided, single submitter | clinical testing | USH2A: PVS1, PM2 |
Counsyl | RCV000671186 | SCV000796138 | pathogenic | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2017-12-07 | criteria provided, single submitter | clinical testing | |
Blueprint Genetics | RCV001074930 | SCV001240536 | pathogenic | Retinal dystrophy | 2017-05-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000416074 | SCV001586257 | pathogenic | not provided | 2023-11-03 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp3702*) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Usher syndrome or retinitis pigmentosa (PMID: 23591405, 26667666). ClinVar contains an entry for this variant (Variation ID: 374674). For these reasons, this variant has been classified as Pathogenic. |
Institute of Medical Genetics and Applied Genomics, |
RCV000416074 | SCV001905661 | pathogenic | not provided | 2021-09-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003449039 | SCV004182139 | pathogenic | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003449038 | SCV004182140 | pathogenic | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003449039 | SCV004208329 | pathogenic | Retinitis pigmentosa 39 | 2023-08-16 | criteria provided, single submitter | clinical testing |